We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Algorithme Pharma Expands Montreal Clinic Facility
News

Algorithme Pharma Expands Montreal Clinic Facility

Algorithme Pharma Expands Montreal Clinic Facility
News

Algorithme Pharma Expands Montreal Clinic Facility

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Algorithme Pharma Expands Montreal Clinic Facility"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Algorithme Pharma has announced the expansion of its clinical facility located in Montreal, Quebec, with the addition of a 7th clinical unit for a total 265 beds.

The modern design enhances the participant experience with 3 independent lounges, soundproof dormitories and facility-wide complimentary WiFi.

The open concept processing and nursing areas enables sponsors to benefit from increased flexibility and efficiency in safely conducting complex study designs requiring large panel sizes.

“In response to our sponsors’ early phase development needs, we’ve added 41 hospital beds to our existing footprint. The new clinic is a great addition to our existing facility. The flexibility in the open concept design allows for increasingly complex protocol functions to occur either in a common area or at the bedside. This design feature, coupled with the ability to perform studies requiring intensive safety monitoring, makes this a unique space. The clinic has been designed for safety, functionality and the comfort of our study participants, and will allow us to continue to increase our service offering in the early phase market.” stated Ingrid Holmes, Vice-President Clinical Operations, Algorithme Pharma Inc.

Advertisement